Apogee Therapeutics CFO Disposes $170,000 in Stock While Company Pursues Multiple Capital Raises
Apogee Therapeutics CFO Jane Henderson sold 2,000 shares of the company’s common stock on March 25, 2026, for $85.00 per share, netting $170,000. The transaction was executed under a Rule 10b5-1 trading plan adopted on September 2, 2025. The move comes amid a flurry of capital-raising activity by the company and after an analyst raised its price ta…